
About Gufic Stridden Bio-Pharma Private Limited
Data last updated:
Gufic Stridden Bio-Pharma Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 27 January 2007.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2007PTC167101. Its GSTIN is 24AADCG1594M1ZD (Gujarat). The company held 2 GST registrations, of which 1 is active.
The company had an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It was led by directors including Dilip Ghosh (Whole-Time Director) and Jayesh Pannalal Choksi.
Its last annual general meeting (AGM) was held on 29 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at 37 First Floor Kamla Bhavan II S Nityanand Road Andheri East, Mumbai, Maharashtra, India – 400069.
As per the financials filed for FY 2017, the company reported a revenue of ₹4.98 Cr, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹68.82 Lakh (net margin 13.8%) and EBITDA of ₹1.02 Cr (EBITDA margin 20.5%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years.
The company has 1 deal on record (1 secondary share transfer); the latest was in April 2008.
The last known website on record is guficbio.com.
Company details
Contact details
Gufic Stridden Bio-Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is guficbio.com. Its e-mail address is in the company report.
- Email
- Website
- Registered Address37 First Floor Kamla Bhavan II S Nityanand Road Andheri East, Mumbai, Maharashtra, India – 400069
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Gufic Stridden Bio-Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Gufic Stridden Bio-Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Gufic Stridden Bio-Pharma Private Limited, buy the company report.
Financials of Gufic Stridden Bio-Pharma Private Limited
FY 2017 filings availableGufic Stridden Bio-Pharma Private Limited reported revenue of ₹4.98 Cr (down 14% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue fell 14% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.02 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹68.82 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 20.5% | ||
| Net Profit Margin | 13.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Gufic Stridden Bio-Pharma Private Limited, buy the company report.
Board of directors of Gufic Stridden Bio-Pharma Private Limited
Gufic Stridden Bio-Pharma has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dilip Ghosh | Whole-Time Director | 27 Jan 2007 | 19 Years 9 Months | As last reported |
| Jayesh Pannalal Choksi | Director | 27 Jan 2007 | 19 Years 9 Months | As last reported |
| Dipanjan Dilip Ghosh | Director | 01 Feb 2012 | 14 Years 8 Months | As last reported |
| Pranav Jayesh Choksi | Director | 27 Jan 2007 | 19 Years 9 Months | As last reported |
Auditor
Gufic Stridden Bio-Pharma Private Limited is audited by B. Bhushan & Associates for the financial year 2014.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B. Bhushan & Associates | FY 2014 |
Shareholding
The shareholding of Gufic Stridden Bio-Pharma Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Gufic Stridden Bio-Pharma Private Limited, buy the company report.
Deals & funding
Gufic Stridden Bio-Pharma Private Limited has 1 deal on record (1 secondary share transfer); the latest was in April 2008.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2008 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Gufic Private Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Gufic Stridden Bio-Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gufic Stridden Bio-Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Gufic Stridden Bio-Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCG1594M1ZD | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Gufic Stridden Bio-Pharma Private Limited, buy the company report.
Recent activity
Gufic Stridden Bio-Pharma Private Limited has 6 board changes on record since 2007: 4 appointments and 2 cessations. The latest: Dipanjan Dilip Ghosh was appointed as Director on 01 Feb 2012.
Frequently asked questions
Gufic Stridden Bio-Pharma has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Gufic Stridden Bio-Pharma was a private limited company based in Mumbai, Maharashtra, India. The company worked in medical and laboratory equipment, within the healthcare industry. It was incorporated on 27 January 2007 and is registered under CIN U24110MH2007PTC167101. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Gufic Stridden Bio-Pharma was incorporated on 27 January 2007. It is registered with the Registrar of Companies, Mumbai.
Gufic Stridden Bio-Pharma had 4 directors:
- Dilip Ghosh - Whole-Time Director
- Jayesh Pannalal Choksi - Director
- Dipanjan Dilip Ghosh - Director
- Pranav Jayesh Choksi - Director
The CIN (Corporate Identification Number) of Gufic Stridden Bio-Pharma is U24110MH2007PTC167101. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Gufic Stridden Bio-Pharma is at 37 First Floor Kamla Bhavan II S Nityanand Road Andheri East, Mumbai, Maharashtra, India – 400069.
Gufic Stridden Bio-Pharma can be reached through the website guficbio.com. Its registered office is in Mumbai, Maharashtra, India.
The latest financial statements of Gufic Stridden Bio-Pharma on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 29 September 2017. Year-wise statements from 2015 are in the company report.
The GSTIN of Gufic Stridden Bio-Pharma is 24AADCG1594M1ZD, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
Gufic Stridden Bio-Pharma operated in the healthcare industry, in the medical and laboratory equipment segment.

